Literature DB >> 34492666

CE: Acute Ischemic Stroke.

Heather H Washington1, Kimberly R Glaser, Nneka Lotea Ifejika.   

Abstract

ABSTRACT: Stroke, the most common form of cerebrovascular disease, is a leading cause of death and disability throughout the world. There have been no significant advances in the development of effective therapeutics for hemorrhagic stroke, and for ischemic stroke highly effective, evidence-based therapies such as alteplase and mechanical thrombectomy are widely underutilized. Improving outcomes for patients experiencing ischemic stroke requires faster recognition and appropriate intervention within the treatment window (the first 24 hours after symptom onset). This article discusses the pathophysiology underlying the various types of ischemic stroke; the risk factors for ischemic stroke; stroke presentation; and the evidence-based treatments, nursing assessments, and monitoring protocols that are critical to patient recovery.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34492666     DOI: 10.1097/01.NAJ.0000790184.66496.1d

Source DB:  PubMed          Journal:  Am J Nurs        ISSN: 0002-936X            Impact factor:   2.577


  1 in total

1.  SATB1/SLC7A11/HO-1 Axis Ameliorates Ferroptosis in Neuron Cells After Ischemic Stroke by Danhong Injection.

Authors:  Sikai Zhan; Jiayin Liang; Huiting Lin; Jiale Cai; Xinxin Yang; Hongwei Wu; Junying Wei; Shumei Wang; Minghua Xian
Journal:  Mol Neurobiol       Date:  2022-10-24       Impact factor: 5.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.